Anogenital ulceration; an unusual presentation of mixed connective disease

Authors

  • Tariq Rashid
  • Saima Ilyas
  • Madiha Zulfiqar

DOI:

https://doi.org/10.66344/jpad.27.1.2017.1034

Keywords:

Mixed connective-tissue disease, systemic lupus erythematosus, scleroderma, antiU1-ribonucleoprotein antibody

Abstract

Mixed connective-tissue disease (MCTD) is an autoimmune disorder with overlapping clinical features of systemic lupus erythematosus (SLE), scleroderma, and myositis, with the presence of antiU1-ribonucleoprotein (RNP) antibody. We report a case of a male patient with unusual clinical presentation of the condition. 

References

Yoshida S. Pulmonary arterial hypertension in connective tissue diseases. Allergol Int. 2011;60:405-9.

Cappelli S, Bellando Randone S, Martinovic D, Tamas MM, Pasalic K, Allanore Y et al. To be or not to be, ten years after: Evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2011;27.

Ungprasert P, Epidemiology of mixed connective tissue disease 1985-2014: A population based study. Arthritis Care Res (Hoboken). 2016. doi: 10.1002/acr.22872.

Downloads

Published

2017-06-13

How to Cite

1.
Rashid T, Ilyas S, Zulfiqar M. Anogenital ulceration; an unusual presentation of mixed connective disease. J Pak Assoc Dermatol [Internet]. 2017Jun.13 [cited 2026Apr.12];27(1):83-5. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1034

Issue

Vol. 27 No. 1 (2017): January - March

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

Most read articles by the same author(s)

1 2 3 > >>